Company Overview

Update
Founded:
1876
Headquarters:
Indianapolis, IN
IPO:
Went Public
Stock:
NYSE:LLY
Categories:
Biotechnology

Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.

Description

Update

Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production. Products Neurosciences products, include: Zyprexa, for the treatment of schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; Cymbalta, for the treatment of major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, and in the United States for the management of fibromyalgia; Strattera, for the treatment of attention-deficit hyperactivity disorder in children, adolescents and adults;... See More

Current Team (5)

Update

Investments (2)

Update

Acquisitions (5)

Update

Offices/Locations (1)

Update
  • Office

    Lilly Corporate Center

    Indianapolis, IN 46285

    USA